Queudeville M, Stein AS, Locatelli F, Ebinger M, et al. Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Cancer 2023 Feb 24. doi: 10.1002/cncr.34667.
PMID: 36829303